1. Romano AA, AllansonJE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al., Noonan Syndrome: Clinical Features, Diagnosis and Management Guidelines. Paediatrics.2010;126(4): 746.
2. Burgt IVD, Noonan Syndrome. Orphanet Journal of Rare Diseases.2007; 2:4.
3. SharlandM, Burch M, Mckenna WM, Patton MA. A clinical study of Noonan Syndrome. Arch Dis Child.1992; 67:178-83.
4. Mendez HMM, Optiz JM. Noonan Syndrome: a review. Am J Med Genet. 1985; 21(3): 493- 506.
5. Nora JJ, Nora AH, Sinha AK,
Spangler R,
Lubs H. The Ullrich-Noonan syndrome (Turner phenotype). Am J Dis Child.1974;127(1):48-55.
6. Heller RH. The Turner phenotype in the male. The journal of Pediatrics.1965; 66(1): 48-63.
8. Cremers CW, Van der Burgt CJ. Hearing loss in Noonan syndrome.Int J PediatrOtorhinolaryngol. 1992; 23(1): 81- 4.
9. Miura M, Sando I, Orita Y, Hirsch BE. Temporal bone histopathological study of Noonan syndrome. IntJournal of Pediatric Otorhinolaryngo- logy. 2001;60: 73-82.
10. Van Trier DC, Van Nierop J, Draaisma JM,
Burgt IV,
Kunst H,
Croonen EA et al. External ear anomalies and hearing impairment in Noonan Syndrome. Int J PediatrOtorhinolaryngol. 2015; 79(6): 874-8.
11. Takahara T, Sando I. Mesenchyme remaining in temporal bones from patients with congenital anomalies. A quantitative histopathologic study. Ann. Otol. Rhinolaryngol. 1987;96(3): 333–9.
12. Matas CG, Leite RA, Goncalves IC, Neves IF. Brainstem Auditory Evoked Potential in Individuals with Conductive and Sensorineural Hearing Losses. 2005; 9(4): 337.
13. Hall J. New handbook of auditory evoked responses. Boston Mass. Pearson. 2007; 232:3.
14. Sand T, The choice of ABR click polarity and amplitude variables in multiple sclerosis patients. ScandAudiol. 1991;20(1) 75-80.
15. Kao CP. Evaluation and management of the child with speech delay. Am Fam Physician.1999; 59(11): 3121-8.